The Lancet Respiratory Medicine
Publisher: Elsevier · ISSN 2213-2600 · 54 articles
- Reshaping COPD care in China: bridging geographical divides and empowering health-care workers
- Preparedness for conflict in medical facilities
- Tuberculosis preventive treatment in high-burden settings: inequality in benefit, evidence, and potential harms
- When spirometry is normal: can FeNO fill the gap in asthma diagnosis?
- In the era of adjuvant alectinib, what can we learn from the E4512 trial of adjuvant crizotinib?
- Understanding US state-level heterogeneity in chronic respiratory disease burden
- Diagnostic labels, GETomics, and biostates in airway diseases
- Inconsistency in prescribing biologics for severe asthma and CRwNP
- European Respiratory Society International Congress 2026
- AI data centres could worsen US air pollution
- Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis
- Accuracy of type 2 inflammatory biomarkers to diagnose asthma in adults and children: a meta-analysis of 30 studies with prospective validation in an adult primary care cohort
- Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group–American College of Radiology Imaging Network E4512): a phase 3 trial
- Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial
- State-level burden of chronic respiratory diseases in the USA, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
- Asthma diagnosis in adults and children: challenges, future directions, and a call to action
- Breathlessness mechanisms, measurement, and management in adults: evidence update on behalf of The Dyspnoea Society
- Obstructive sleep apnoea: an overlooked challenge in the current NHS Strategy
- Laennec beyond the stethoscope
- Defining residual lung disease with CFTR modulators
- Consensus on the definition, components, and grading of composite postoperative pulmonary complication outcomes (PrECiSIOn): insights from an international Delphi expert panel
- Ending the global neglect of pneumonia: from awareness to accountability
- Longitudinal change in FEV1 in adults with cystic fibrosis treated with elexacaftor–tezacaftor–ivacaftor in France: a prospective observational study
- RSV multidose vaccine puts Africa's RSV burden in focus